Medipixel
About Medipixel
Medipixel is a leading healthcare AI company specializing in advanced software solutions for cardiovascular and cerebrovascular image analysis. Their flagship product, MPXA, leverages artificial intelligence to automatically identify and quantify stenosis in cardiovascular angiographies, providing real-time, highly accurate analysis to assist physicians during interventional procedures such as stent placements. This technology has received approvals from both the Korea Food & Drug Administration (2021) and the U.S. FDA (March 2023).
Beyond anatomical analysis, Medipixel is developing MPFFR for the functional diagnosis of the cardiovascular system, which recently secured conditional approval under Korea’s New Health Technology Assessment (nHTA) program, enabling hospitals to bill for the test. The company has also expanded its expertise into neurovascular care with MPNeuro, a software for 3D cerebrovascular modeling and analysis, which obtained Class II medical device certification from the Korean Ministry of Food and Drug Safety in February 2025. Medipixel’s overarching vision is to create a “Continuous Intelligence” platform that supports the entire interventional workflow, from pre-procedure diagnosis and planning to intervention and post-procedure validation, aiming to enhance procedural efficiency, reduce radiation exposure, and optimize healthcare resource utilization for improved patient outcomes.
Focus Areas
Business Intelligence
| Key Investors | Premier Partners, Company K Partners, IMM Investment, SBI Investment, IBK Industrial Bank, Quad Investment Management, Dayli Partners, Mirae Asset, MedTech Innovator, AI Angel Club |
| Partnerships | Innvolution Group (India), pursuing co-development partnerships with U.S.-based companies, potential partnerships with global imaging companies like Philips, Siemens, and Canon |
| Technology | AI-based medical software, computer vision, deep learning, reinforcement learning, real-time analysis, Software as a Medical Device (SaMD), cloud-native (implied) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Medipixel's solutions offer significant advantages by providing real-time, highly accurate, and automated analysis directly within the cath lab workflow. MPXA can streamline stent placement decisions, while MPFFR's non-invasive FFR assessment can reduce patient burden and procedural time, allowing for more precise treatment strategies based on both anatomical and functional insights. MPNeuro provides critical 3D insights for complex cerebrovascular interventions. The speed of analysis (e.g., MPXA in ~1.8 seconds, MPFFR in ~7 seconds, MPNeuro 3D plane in ~2 seconds) means instant decision support, which is crucial in time-sensitive interventional settings.
Medipixel's software-based architecture is designed for seamless integration into existing cath lab environments without interruption. They have established a strategic partnership with Philips, indicating potential for deeper integration with global cardiovascular imaging equipment. The ability for a single server to connect to multiple procedure rooms simultaneously highlights its adaptability.
Reviews & Opinions
Videos
News, demos, and interviews about Medipixel.
Videos load interactively. If none appear, search YouTube for Medipixel →
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]